March 20, 2025
TOPLINE: The recombinant zoster vaccine (RZV) Shingrix demonstrated effectiveness in preventing herpes zoster (HZ) and postherpetic neuralgia among adults aged 50 years or older with rheumatoid […]
March 20, 2025
Despite the widespread benefits of GLP-1 agonists as an obesity treatment, the medications remain out of reach for many patients . The list price for GLP-1 […]
March 20, 2025
TOPLINE: Urine test strip analysis emerged as a valuable screening tool for chronic kidney disease (CKD) in low-risk individuals, with the albumin-to-creatinine ratio (ACR) showing higher […]
March 20, 2025
TOPLINE: Individuals with high genetic susceptibility to type 2 diabetes (T2D) who watched television for ≤ 1 hour/day had a lower 10-year absolute risk for atherosclerotic […]
March 20, 2025
TOPLINE: Upadacitinib was well tolerated in patients with moderate to severe atopic dermatitis (AD) and led to disease control as early as 1 month, with sustained […]
March 20, 2025
TOPLINE: In patients with symptomatic severe aortic stenosis at intermediate or higher surgical risk, CoreValve or Evolut transcatheter aortic valve implantation (TAVI) was associated with a […]
March 20, 2025
The demand for glucagon-like peptide 1 (GLP-1) receptor agonists for overweight/obesity has created a clinical conundrum for many primary care providers. Between 2011 and 2023, obesity-specific […]
March 20, 2025
TOPLINE: Discontinuing oxytocin during active labor was associated with a 20% lower risk for cesarean delivery and reduced the risk for uterine tachysystole and non-reassuring fetal […]
March 20, 2025
TOPLINE: Poor outcomes in patients with cutaneous squamous cell carcinoma (CSCC) were more likely if they had additional risk factors, a multinational study found. METHODOLOGY: A […]
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441442443444445446447448449450451452453454455456457458459460461462463464465466467468469470471472473474475476477478479480481482483484485486487488489490491492493494495496497498499500501502503504505506507508509510511512513514515516517518519520521522523524525526527528529530531532533534535536537538539540541542543544545546547548549550551552553554555556557558559560561562563564565566567568569570571572573574575576577578579580581582583584585586587588589590591592593594595596597598599600601602603604605606607608609610611612613614615616617618619620621622623624625626627628629630631632633634635636637638639640641642643644645646647648649650651652
Next page